Default company panoramic image
Logo

Claro Scientific, LLC

SpectraWave is an innovative reagentless system for point of care medical diagnostics that characterizes patient samples in less than 5 minutes.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location St. Petersburg, FL, USA
  • Currency USD
  • Employees 9
  • Website clarosci.com

Company Summary

Claro has developed SpectraWave to be a disruptive system, redefining how optics can be applied to medical and patient monitoring applications. Claro’s breakthrough is in delivering a powerful combination of unique and confirmatory information by integrating several discrete optical analysis methods. This innovation means SpectraWave can achieve the levels of sensitivity and specificity and limits of detection needed to meet today’s requirements.

Team

  • Default avatar
    Thomas McLain
    CEO

    Tom is the CEO of Claro Scientific. He is also a member of the board of directors and executive committee of BioFlorida, an industry association dedicated to advancing Florida’s bioscience, life science and medical device economy. He served as BioFlorida’s chairman from 2004 through 2010. Previously, Tom was the Chairman, Chief Executive Officer, and President of Nabi Biopharmaceuticals, a Florida based biotechnology company applying its know

  • Default avatar
    Luis Garcia-Rubio
    Founder, President and CSO

    Dr. Garcia-Rubio is a world renowned engineer and scientist with expertise in optics and particle analysis. A serial entrepreneur, he was principal/co-founder of Ocean Optics creating a $600 million market through launch of the world’s first high resolution miniaturized spectrometers. His expertise is now directed to applications of optics and algorithms that are advancing rapid, accurate and innovative medical and biotech analysis systems.

  • Default avatar
    Debra Huffman
    Senior Principal Scientist

    Dr. Huffman brings over 20 yrs of technical experience in infectious disease detection to Claro. Her research includes the development of methods for the detection of pathogenic organisms in matrices ranging from bodily fluids to drinking water. Dr. Huffman contributes her clinical laboratory expertise to the research and development of diagnostic products and is a key inventor and developer of Claro’s second-generation intellectual property.

  • Default avatar
    Jack Lindon
    Research Fellow

    Dr. Lindon has extensive product development experience in medical and personal care products. At Baxter Healthcare he focused on blood analysis and established a Thrombosis, Hemostasis and Blood Compatibility testing facility. Later at Kimberly Clark his research focused on the properties and handling techniques for human body fluids. Now at Claro his expertise is focused on fluid systems for processing bacterial, protein and cellular samples.

Advisors

  • Default avatar
    Edwards Wildman Palmer LLP, West Palm Beach, FL - Les Croland
    Lawyer
    Unconfirmed
    Default avatar
    Cherry, Bekaert & Holland, Tampa, FL - Phil Piser and David Appel
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Luis Garcia-Rubio, Founder
    Unconfirmed
    Default avatar
    Friends and Family Round
    Unconfirmed